| RS1057518987 |
ANKRD11
|
Health Risk |
Pathogenic |
Moderate intellectual deficiency, KBG syndrome |
| RS1057518988 |
GRIN2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy, intellectual deficiency |
| RS1057518989 |
STXBP1
|
Health Risk |
Likely pathogenic |
Severe intellectual deficiency, Severe intellectual deficiency |
| RS1057518991 |
ADNP
|
Health Risk |
Pathogenic/Likely pathogenic |
Autism, severe |
| RS1057518992 |
NFIA
|
Health Risk |
Likely pathogenic |
Macrocephaly, Cleft palate |
| RS1057518993 |
IQSEC2
|
Health Risk |
Likely pathogenic |
Severe intellectual deficiency, Autism |
| RS1057518994 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
intellectual deficiency, Epilepsy |
| RS1057518995 |
KLF7
|
Health Risk |
Pathogenic/Likely pathogenic |
intellectual deficiency, KLF7-related disorder |
| RS1057518999 |
FOXP1
|
Health Risk |
Likely pathogenic |
Autism, Autism |
| RS1057519000 |
SLC35A2
|
Health Risk |
Likely pathogenic |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS1057519002 |
ARID1B
|
Health Risk |
Likely pathogenic |
dysmorphy, intellectual deficiency |
| RS1057519004 |
GRIN2B
|
Health Risk |
Pathogenic/Likely pathogenic |
intellectual deficiency, Intellectual disability |
| RS1057519005 |
ASXL3
|
Health Risk |
Pathogenic |
Language retardation, intellectual deficiency |
| RS1057519006 |
PORCN
|
Health Risk |
Likely pathogenic |
Focal dermal hypoplasia, Focal dermal hypoplasia |
| RS1057519007 |
USP9X
|
Health Risk |
Likely pathogenic |
Severe intellectual deficiency, Severe intellectual deficiency |
| RS1057519009 |
ARID1B
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome, Coffin-Siris syndrome |
| RS1057519010 |
SCN2A
|
Health Risk |
Likely pathogenic |
intellectual deficiency, intellectual deficiency |
| RS1057519012 |
EP300
|
Health Risk |
Likely pathogenic |
Microcephaly, intellectual deficiency |
| RS1057519014 |
RARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe intellectual deficiency, Pontocerebellar hypoplasia type 6 |
| RS1057519015 |
HCN4
|
Health Risk |
Pathogenic |
Sick sinus syndrome 2, autosomal dominant |
| RS1057519017 |
LARP7
|
Health Risk |
Pathogenic |
Microcephalic primordial dwarfism, Alazami type |
| RS1057519018 |
XPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Xeroderma pigmentosum group A, Xeroderma pigmentosum |
| RS1057519019 |
LINS1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 27 |
| RS1057519021 |
GM2A
|
Health Risk |
Likely pathogenic |
Tay-Sachs disease, variant AB |
| RS1057519022 |
GM2A
|
Health Risk |
Likely pathogenic |
Tay-Sachs disease, variant AB |
| RS1057519023 |
MME
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2T, Charcot-Marie-Tooth disease axonal type 2T |
| RS1057519024 |
MME
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2T, Charcot-Marie-Tooth disease axonal type 2T |
| RS1057519025 |
C1R
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, periodontal type 1 |
| RS1057519026 |
C1R;C1RL
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, periodontal type 1 |
| RS1057519027 |
BBS7
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome |
| RS1057519028 |
THRB
|
Health Risk |
Likely pathogenic |
Thyroid hormone resistance, generalized |
| RS1057519029 |
ATM
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1057519033 |
EFNB1
|
Health Risk |
Likely pathogenic |
Craniofrontonasal syndrome, Craniofrontonasal syndrome |
| RS1057519034 |
EFNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Craniofrontonasal syndrome, Craniofrontonasal syndrome |
| RS1057519035 |
EFNB1
|
Health Risk |
Pathogenic |
Craniofrontonasal syndrome, Craniofrontonasal syndrome |
| RS1057519036 |
FGFR2
|
Health Risk |
Pathogenic |
Crouzon syndrome, FGFR2-related craniosynostosis |
| RS1057519037 |
FGFR2
|
Health Risk |
Pathogenic |
Pfeiffer syndrome, FGFR2-related craniosynostosis |
| RS1057519038 |
FGFR2
|
Health Risk |
Likely pathogenic |
Crouzon syndrome, FGFR2-related craniosynostosis |
| RS1057519039 |
FGFR2
|
Health Risk |
Likely pathogenic |
Crouzon syndrome, FGFR2-related craniosynostosis |
| RS1057519040 |
FGFR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Crouzon syndrome, Crouzon syndrome |
| RS1057519041 |
FGFR2
|
Health Risk |
Pathogenic |
Pfeiffer syndrome, FGFR2-related craniosynostosis |
| RS1057519042 |
FGFR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Crouzon syndrome, Crouzon syndrome |
| RS1057519043 |
FGFR2
|
Health Risk |
Pathogenic |
Crouzon syndrome, FGFR2-related craniosynostosis |
| RS1057519044 |
FGFR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Crouzon syndrome, 11 conditions |
| RS1057519045 |
FGFR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Crouzon syndrome, Pemigatinib resistance |
| RS1057519046 |
FGFR2
|
Health Risk |
Likely pathogenic |
Craniosynostosis, nonspecific |
| RS1057519047 |
FGFR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pfeiffer syndrome, FGFR2-related craniosynostosis |
| RS1057519049 |
FGFR3
|
Health Risk |
Likely pathogenic |
Craniosynostosis, nonspecific |
| RS1057519050 |
TBX5
|
Health Risk |
Likely pathogenic |
Familial atrioventricular septal defect, Familial atrioventricular septal defect |
| RS1057519051 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1057519052 |
DENND3
|
Health Risk |
Likely pathogenic |
Hirschsprung disease, susceptibility to |
| RS1057519053 |
DCC
|
Health Risk |
Pathogenic |
Corpus callosum, agenesis of |
| RS1057519054 |
DCC
|
Health Risk |
Pathogenic |
Corpus callosum, agenesis of |
| RS1057519055 |
DCC
|
Health Risk |
Pathogenic |
Corpus callosum, agenesis of |
| RS1057519056 |
DCC
|
Health Risk |
Pathogenic |
Corpus callosum, agenesis of |
| RS1057519057 |
DCC
|
Health Risk |
Pathogenic |
Corpus callosum, agenesis of |
| RS1057519059 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1057519062 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Angelman syndrome |
| RS1057519063 |
VPS33B
|
Health Risk |
Pathogenic |
Arthrogryposis, renal dysfunction |
| RS1057519067 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1057519069 |
CYP21A2
|
Health Risk |
Pathogenic |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS1057519073 |
NDUFB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 30 |
| RS1057519074 |
MSN
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to moesin deficiency, Combined immunodeficiency due to moesin deficiency |
| RS1057519075 |
MSN
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to moesin deficiency, Combined immunodeficiency due to moesin deficiency |
| RS1057519076 |
KCNN4
|
Health Risk |
Likely pathogenic |
Dehydrated hereditary stomatocytosis 2, Dehydrated hereditary stomatocytosis 2 |
| RS1057519077 |
KCNN4
|
Health Risk |
Likely pathogenic |
Dehydrated hereditary stomatocytosis 2, Dehydrated hereditary stomatocytosis 2 |
| RS1057519078 |
KIF5A
|
Health Risk |
Pathogenic |
Myoclonus, intractable |
| RS1057519079 |
IL17RA
|
Health Risk |
Pathogenic |
Immunodeficiency 51, Immunodeficiency 51 |
| RS1057519080 |
HTRA2
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria type 8, 3-methylglutaconic aciduria type 8 |
| RS1057519081 |
HTRA2
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria type 8, 3-methylglutaconic aciduria type 8 |
| RS1057519082 |
HTRA2
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria type 8, 3-methylglutaconic aciduria type 8 |
| RS1057519083 |
DCPS
|
Health Risk |
Pathogenic |
Al-Raqad syndrome, Al-Raqad syndrome |
| RS1057519084 |
NDUFAF6
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 17 |
| RS1057519085 |
NDUFAF6
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 17 |
| RS1057519087 |
MFSD2A
|
Health Risk |
Pathogenic |
Microcephaly 15, primary |
| RS1057519090 |
COL4A2
|
Health Risk |
Pathogenic |
— |
| RS1057519092 |
EBF3
|
Health Risk |
Likely pathogenic |
Hypotonia, ataxia |
| RS1057519093 |
TNNI2
|
Health Risk |
Likely pathogenic |
— |
| RS1057519097 |
AICDA
|
Health Risk |
Likely pathogenic |
— |
| RS1057519098 |
GNAL
|
Health Risk |
Pathogenic |
— |
| RS1057519101 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral arteriopathy, autosomal dominant |
| RS1057519105 |
DNAH11
|
Health Risk |
Likely pathogenic |
— |
| RS1057519106 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Dystrophin deficiency |
| RS1057519107 |
DEPDC5
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS1057519108 |
SPAST
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1057519112 |
SLC25A15
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome |
| RS1057519117 |
SBF1
|
Health Risk |
Likely pathogenic |
— |
| RS1057519118 |
CYP19A1;MIR4713HG;PIRC66
|
Health Risk |
Likely pathogenic |
— |
| RS1057519124 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS1057519126 |
LRP5
|
Health Risk |
Pathogenic |
— |
| RS1057519127 |
LRP5
|
Health Risk |
Likely pathogenic |
— |
| RS1057519128 |
LMOD3
|
Health Risk |
Pathogenic |
Nemaline myopathy 10, Nemaline myopathy 10 |
| RS1057519129 |
LMOD3
|
Health Risk |
Pathogenic |
Nemaline myopathy 10, Nemaline myopathy 10 |
| RS1057519130 |
COL9A1
|
Health Risk |
Pathogenic |
— |
| RS1057519131 |
FXN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1057519132 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1057519133 |
ALMS1
|
Health Risk |
Likely pathogenic |
— |
| RS1057519134 |
SPTLC2
|
Health Risk |
Pathogenic |
— |
| RS1057519136 |
LCA5
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS1057519141 |
KIF11
|
Health Risk |
Likely pathogenic |
— |